Adam Feuerstein is a senior columnist for TheStreet, investigating biotech stocks. Before joining TheStreet in March 2001, Feuerstein covered business software for Upside.com. He also covered a variety of business beats, including technology and commercial real estate, at the San Francisco Business Times.
Bio
- @AdamFeuerstein
Specialties:
- Hepatology
Location:
- NY